These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 29749470)
1. Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma. Cao Q; Ruan H; Wang K; Song Z; Bao L; Xu T; Xiao H; Wang C; Cheng G; Tong J; Meng X; Liu D; Yang H; Chen K; Zhang X Int J Oncol; 2018 Jul; 53(1):137-147. PubMed ID: 29749470 [TBL] [Abstract][Full Text] [Related]
2. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway. Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172 [TBL] [Abstract][Full Text] [Related]
3. Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma. Xu GH; Lou N; Shi HC; Xu YC; Ruan HL; Xiao W; Liu L; Li X; Xiao HB; Qiu B; Bao L; Yuan CF; Zhou YL; Hu WJ; Chen K; Yang HM; Zhang XP BMC Cancer; 2018 Jan; 18(1):88. PubMed ID: 29357836 [TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway. Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma. Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417 [TBL] [Abstract][Full Text] [Related]
6. TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma. Pan Q; Cheng G; Liu Y; Xu T; Zhang H; Li B Int J Oncol; 2020 May; 56(5):1101-1114. PubMed ID: 32319572 [TBL] [Abstract][Full Text] [Related]
7. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma. Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023 [TBL] [Abstract][Full Text] [Related]
8. RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma. Liu Y; Cheng G; Song Z; Xu T; Ruan H; Cao Q; Wang K; Bao L; Liu J; Zhou L; Liu D; Yang H; Chen K; Zhang X Int J Oncol; 2019 Sep; 55(3):645-656. PubMed ID: 31364727 [TBL] [Abstract][Full Text] [Related]
9. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma. Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma. Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma. Huang JL; Liao Y; Qiu MX; Li J; An Y Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366 [TBL] [Abstract][Full Text] [Related]
12. RCAN1.4 acts as a suppressor of cancer progression and sunitinib resistance in clear cell renal cell carcinoma. Song Z; Cao Q; Ruan H; Yang H; Wang K; Bao L; Cheng G; Xu T; Xiao H; Wang C; Liu D; Chen K; Zhang X Exp Cell Res; 2018 Nov; 372(2):118-128. PubMed ID: 30267660 [TBL] [Abstract][Full Text] [Related]
13. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor. Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177 [TBL] [Abstract][Full Text] [Related]
14. KCNJ1 inhibits tumor proliferation and metastasis and is a prognostic factor in clear cell renal cell carcinoma. Guo Z; Liu J; Zhang L; Su B; Xing Y; He Q; Ci W; Li X; Zhou L Tumour Biol; 2015 Feb; 36(2):1251-9. PubMed ID: 25344677 [TBL] [Abstract][Full Text] [Related]
15. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma. Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595 [TBL] [Abstract][Full Text] [Related]
16. miR‑122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3. Nie W; Ni D; Ma X; Zhang Y; Gao Y; Peng C; Zhang X Int J Oncol; 2019 Feb; 54(2):559-571. PubMed ID: 30483771 [TBL] [Abstract][Full Text] [Related]
17. Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma. Mitsui Y; Shiina H; Kato T; Maekawa S; Hashimoto Y; Shiina M; Imai-Sumida M; Kulkarni P; Dasgupta P; Wong RK; Hiraki M; Arichi N; Fukuhara S; Yamamura S; Majid S; Saini S; Deng G; Dahiya R; Nakajima K; Tanaka Y Mol Cancer Res; 2017 Jul; 15(7):884-895. PubMed ID: 28242813 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma. Su H; Wang H; Shi G; Zhang H; Sun F; Ye D Eur J Surg Oncol; 2018 Jun; 44(6):840-846. PubMed ID: 29433989 [TBL] [Abstract][Full Text] [Related]
19. Golgi Alpha-Mannosidase II as a Novel Biomarker Predicts Prognosis in Clear Cell Renal Cell Carcinoma. Li C; Guo L; Chen F; Yu W; Rao T; Ruan Y Oncol Res Treat; 2020; 43(6):264-275. PubMed ID: 32403105 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma. Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]